Skip to main content

Estrogens and prostate cancer.

Publication ,  Journal Article
Dobbs, RW; Malhotra, NR; Greenwald, DT; Wang, AY; Prins, GS; Abern, MR
Published in: Prostate Cancer Prostatic Dis
May 2019

BACKGROUND: Hormonal influences such as androgens and estrogens are known contributors in the development and progression of prostate cancer (CaP). While much of the research to the hormonal nature of CaP has focused on androgens, estrogens also have critical roles in CaP development, physiology as well as a potential therapeutic intervention. METHODS: In this review, we provide a critical literature review of the current basic science and clinical evidence for the interaction between estrogens and CaP. RESULTS: Estrogenic influences in CaP include synthetic, endogenous, fungi and plant-derived compounds, and represent a family of sex hormones, which cross hydrophobic cell membranes and bind to membrane-associated receptors and estrogen receptors that localize to the nucleus triggering changes in gene expression in various organ systems. CONCLUSIONS: Estrogens represent a under-recognized contributor in CaP development and progression. Further research in this topic may provide opportunities for identification of environmental influencers as well as providing novel therapeutic targets in the treatment of CaP.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Prostate Cancer Prostatic Dis

DOI

EISSN

1476-5608

Publication Date

May 2019

Volume

22

Issue

2

Start / End Page

185 / 194

Location

England

Related Subject Headings

  • Urology & Nephrology
  • Signal Transduction
  • Receptors, Estrogen
  • Prostatic Neoplasms
  • Prostate
  • Obesity
  • Male
  • Humans
  • Gene Expression Regulation
  • Estrogens
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Dobbs, R. W., Malhotra, N. R., Greenwald, D. T., Wang, A. Y., Prins, G. S., & Abern, M. R. (2019). Estrogens and prostate cancer. Prostate Cancer Prostatic Dis, 22(2), 185–194. https://doi.org/10.1038/s41391-018-0081-6
Dobbs, Ryan W., Neha R. Malhotra, David T. Greenwald, Alice Y. Wang, Gail S. Prins, and Michael R. Abern. “Estrogens and prostate cancer.Prostate Cancer Prostatic Dis 22, no. 2 (May 2019): 185–94. https://doi.org/10.1038/s41391-018-0081-6.
Dobbs RW, Malhotra NR, Greenwald DT, Wang AY, Prins GS, Abern MR. Estrogens and prostate cancer. Prostate Cancer Prostatic Dis. 2019 May;22(2):185–94.
Dobbs, Ryan W., et al. “Estrogens and prostate cancer.Prostate Cancer Prostatic Dis, vol. 22, no. 2, May 2019, pp. 185–94. Pubmed, doi:10.1038/s41391-018-0081-6.
Dobbs RW, Malhotra NR, Greenwald DT, Wang AY, Prins GS, Abern MR. Estrogens and prostate cancer. Prostate Cancer Prostatic Dis. 2019 May;22(2):185–194.

Published In

Prostate Cancer Prostatic Dis

DOI

EISSN

1476-5608

Publication Date

May 2019

Volume

22

Issue

2

Start / End Page

185 / 194

Location

England

Related Subject Headings

  • Urology & Nephrology
  • Signal Transduction
  • Receptors, Estrogen
  • Prostatic Neoplasms
  • Prostate
  • Obesity
  • Male
  • Humans
  • Gene Expression Regulation
  • Estrogens